Literature DB >> 17017883

Modifications to increase the efficiency of the fluorometric cycling assay for cyclic ADP-ribose.

Genevieve S Young1, James B Kirkland.   

Abstract

Cyclic ADP-ribose (cADPR) is an intracellular messenger that triggers the release of calcium ions from intracellular stores in a variety of cell types. The fluorometric cycling assay has become the preferred method for measuring cADPR due to its high level of sensitivity (in the sub-nanomolar range) and its use of commercially available reagents. Additionally, the assay is performed in multiwell plates, making it suitable for high throughput screening using a fluorescence plate reader. The findings reported in this paper present several problems that may be encountered during various stages of the assay, and provide solutions to these problems. Modifications to the assay address reduced recovery of sample and cADPR with removal of perchloric acid (PCA) using organic solvent, reduction in diaphorase activity with heat treatment, and effects on resorufin fluorescence by pH range. Using these modifications, we report an increase of approximately 15% in recovery of brain cADPR, and show that between-subject variability is greatly reduced. We hope that these observations will encourage more widespread application of this valuable assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017883     DOI: 10.2174/138620706778249749

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  2 in total

1.  Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.

Authors:  Julia E Rasmussen; John T Sheridan; William Polk; Catrin M Davies; Robert Tarran
Journal:  J Biol Chem       Date:  2014-01-21       Impact factor: 5.157

Review 2.  Does Cyclic ADP-Ribose (cADPR) Activate the Non-selective Cation Channel TRPM2?

Authors:  Ralf Fliegert; Winnie M Riekehr; Andreas H Guse
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.